Skip Navigation
Department of Health and Human Services
Slide Tray
0 slides

Return to Slide Library


Add Presentation to Slide Tray Presentation:

Progestogens for Prevention of Preterm Birth

Slide: 7 of 29

Progestogens for Preventing Preterm Birth (2 of 2)

Formulations of progestogens have been approved by the U.S. Food and Drug Administration (FDA) but for indications other than prevention of preterm birth. These forms include:

  • Vaginal suppositories, gels, and caps
  • Oral formulations

A commercial formulation of progesterone for intramuscular injection has been approved for preterm birth prevention (17 alpha-hyddroxyprgesteron caproate). Formulations of progestogens may be supplied by compounding pharmacies.